Daisy Bell Inc. – Trademark Portfolio
Entity Type: 03
Daisy Bell Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DAISY BELL. The owner is based in New York, NY.
1632 First Avenue, Suite 256
New York, NY 10028
Showing of trademarks Trademarks
Trademark Classifications
Daisy Bell Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Legal services; security services for the protection of property and individuals
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Daisy Bell Inc. have?
Daisy Bell Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Daisy Bell Inc. file in?
Daisy Bell Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 45 (Legal & Security Services), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Daisy Bell Inc.'s most well-known trademarks?
Daisy Bell Inc.'s registered trademark portfolio includes well-known marks such as DAISY BELL. These are among 1 currently registered trademark in the portfolio.
What is Daisy Bell Inc.'s trademark registration success rate?
Daisy Bell Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.